Activation of Src should be relevant for activation of YAP and upregulation of IL-6 in MDA-MB-231 breast cancer cells since inhibition of Src by PP2 or silencing Src expression in these cells decreases PY-YAP and downregulates IL-6 expression (Fig. 2D). Here, IL6 is linked to breast cancer.